Anthony B Cashen Net Worth

The estimated Net Worth of Anthony B Cashen is at least $230 Tisíc dollars as of 4 April 2006. Anthony Cashen owns over 12,500 units of Immucell stock worth over $128,011 and over the last 19 years Anthony sold ICCC stock worth over $101,625.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Anthony Cashen ICCC stock SEC Form 4 insiders trading

Anthony has made over 3 trades of the Immucell stock since 2005, according to the Form 4 filled with the SEC. Most recently Anthony sold 12,500 units of ICCC stock worth $84,375 on 4 April 2006.

The largest trade Anthony's ever made was exercising 15,000 units of Immucell stock on 21 June 2005 worth over $52,500. On average, Anthony trades about 10,000 units every 96 days since 2005. As of 4 April 2006 Anthony still owns at least 33,776 units of Immucell stock.

You can see the complete history of Anthony Cashen stock trades at the bottom of the page.

What's Anthony Cashen's mailing address?

Anthony's mailing address filed with the SEC is C/O IMMUCELL CORP, 56 EVERGREEN DRIVE, PORTLAND, ME, 04103.

Insiders trading at Immucell

Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin a Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.

What does Immucell do?

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.

Complete history of Anthony Cashen stock trades at Immucell

Immucell executives and stock owners

Immucell executives and other stock owners filed with the SEC include:

• Michael F. Brigham,
  Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director
• Michael Brigham,
  President, Chief Executive Officer, Treasurer, Secretary, Director
• Bobbi Brockmann,
  Vice President - Sales and Marketing, Director
• Elizabeth Williams,
  Vice President - Manufacturing Operations
• Elizabeth L. Williams,
  VP of Manufacturing Operations
• Dr. Joseph H. Crabb Ph.D.,
  VP & Chief Scientific Officer
• Joseph Crabb,
  Chief Scientific Officer, Vice President
• David Tomsche,
  Chairman of the Board
• Paul Wainman,
  Independent Director
• Jonathan Rothschild,
  Independent Director
• Steven Rosgen,
  Independent Director
• David Cunningham,
  Independent Director
• John W. Zinckgraf,
  Director of Product Devel.
• A. Gustavo Scaffa,
  Sr. Director of Quality
• Elizabeth S. Toothaker,
  Director of Fin. & Admin.
• Linda Rhodes,
  Director
• Brian L. Pessin,
  
• Norman H Pessin,
  
• Gloria F Basse,
  Director
• Anthony B Cashen,
  Director
• Robert C Bruce,
  Director
• William H Maxwell,
  Director
• Bryan K. Gathagan,